Pharmaceuticals 2010, 3(11), 3355-3370; doi:10.3390/ph3113355
Review

Inactivation of Anandamide Signaling: A Continuing Debate

School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, Scotland, UK
* Author to whom correspondence should be addressed.
Received: 25 August 2010; in revised form: 9 October 2010 / Accepted: 25 October 2010 / Published: 28 October 2010
(This article belongs to the Special Issue Cannabinoids)
PDF Full-text Download PDF Full-Text [186 KB, uploaded 28 October 2010 10:36 CEST]
Abstract: Since the first endocannabinoid anandamide was identified in 1992, extensive research has been conducted to characterize the elements of the tightly controlled endocannabinoid signaling system. While it was established that the activity of endocannabinoids are terminated by a two-step process that includes cellular uptake and degradation, there is still a continuing debate about the mechanistic role of these processes in inactivating anandamide signals.
Keywords: endocannabinoid inactivation; anandamide; ethanolamine

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Khairy, H.; Houssen, W.E. Inactivation of Anandamide Signaling: A Continuing Debate. Pharmaceuticals 2010, 3, 3355-3370.

AMA Style

Khairy H, Houssen WE. Inactivation of Anandamide Signaling: A Continuing Debate. Pharmaceuticals. 2010; 3(11):3355-3370.

Chicago/Turabian Style

Khairy, Hesham; Houssen, Wael E. 2010. "Inactivation of Anandamide Signaling: A Continuing Debate." Pharmaceuticals 3, no. 11: 3355-3370.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert